Liberi Insights
Biotechs That Trust Us
Latest article
Do’s and Don’ts with a slide deck
July 31, 2025
In biotech, your slide deck isn’t just a formality – it’s your first business case.At Liberi Group, we’ve reviewed and refined hundreds of decks over the years, across investor pitches, pharma partnering, and BD outreach. The patterns are clear: strong materials open doors, weak…
Read more


Don’t Call it AI if it isn’t
July 31, 2025
Tri-Specific Antibodies: Why the Next Generation of Biologics Matters for BD
July 31, 2025
Acute vs. Chronic: Why Pharma’s Focus is Long-Term (and What that Means for BD)
July 31, 2025
Accessing Non-FDA Approved Drugs for Individual Treatment
March 11, 2025
Out-Licensing in Biotech: How to Successfully Commercialize Innovation?
February 21, 2025
How to maximize the value of licensing deals in life sciences?
February 7, 2025
How to build strategic partnerships in early-stage biotech?
February 7, 2025
Biotech Partnerships in 2025: Trends and Opportunities
February 7, 2025










